Organigram Holdings Inc. Net Income

Net Income of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Income growth rates and interactive chart. Net income (NI), also called net earnings, is calculated as sales minus cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes, and other expenses. It is the profit available to all shareholders, both preferred and common.


Highlights and Quick Summary

  • Net Income for the quarter ending August 31, 2022 was $-4.82 Million (a 119.82% increase compared to previous quarter)
  • Year-over-year quarterly Net Income increased by 373.15%
  • Annual Net Income for 2022 was $-11.2 Million (a -89.17% decrease from previous year)
  • Annual Net Income for 2021 was $-104 Million (a -0.2% decrease from previous year)
  • Annual Net Income for 2020 was $-104 Million (a 1354.5% increase from previous year)
  • Twelve month Net Income ending August 31, 2022 was $-11.2 Million (a -58.45% decrease compared to previous quarter)
  • Twelve month trailing Net Income decreased by -85.59% year-over-year
Trailing Net Income for the last four month:
31 Aug '22 31 May '22 28 Feb '22 30 Nov '21
$-11.2 Million $-27 Million $-28.1 Million $-77.9 Million
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Income of Organigram Holdings Inc.

Most recent Net Incomeof OGI including historical data for past 10 years.

Interactive Chart of Net Income of Organigram Holdings Inc.

Organigram Holdings Inc. Net Income for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-4.82 $-2.19 $-3.19 $-11.23
2021 $-1.02 $-20.61 $-3.31 $-52.95 $-103.73
2020 $-26.08 $-31.47 $-63.98 $-5.19 $-103.94
2019 $-0.65 $-16.83 $-7.7 $-5.2 $-7.15
2018 $22.56 $17.33 $17.02
2017 $-8.51
2016 $0.65

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic